An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease

Gregory M. Chronowski, Richard B. Wilder, Susan L. Tucker, Chul S. Ha, Andreas H. Sarris, Fredrick B. Hagemeister, Ibrahim Barista, Mark A. Hess, Fernando Cabanillas, James D. Cox

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease'. Together they form a unique fingerprint.

Medicine & Life Sciences